Patrick Mayrhofer
Dr. Patrick Mayrhofer MSc.
Status
ORCID: 0000-0003-4763-5911
56335497100: AuthorId
M-6458-2018: ResearcherId
Projekte
Es wurden 0 Projekte gefunden.
Publikationen
Wissentransfer in die Gesellschaft
Medienbeiträge
Vorträge
(2022) Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells
Autoren: Hunjadi, M; Mayrhofer, P; Abdur, R; Kunert, R
27th European Society for Animal Cell Technology ESACT Meeting 2022
(2019) DoE-supported perfusion medium development for maximum cell densities and optimized media consumption
Autoren: Mayrhofer, P; Damjanovic, L; Castan, A; Kunert, R
257th National Spring Meeting of the American Chemical Society ACS 2019
(2019) DoE-supported media formulations in high density perfusion processes
Autoren: Kunert, R; Castan, A; Mayrhofer, P
2nd Global Bioprocessing, Bioanalytics & ATMP Manufacturing Congress
(2019) Gene expression changes in response to expressed mAb variant in CHO cells
Autoren: Schwaigerlehner, L; Akhtar, S; Scholey, R; Torres, M; Mayrhofer, P; Dickson, AJ; Kunert, R
14th Asian Congress on Biotechnology ACB 2019
(2019) Influence of Somatic Mutations on mAb Expression and Thermal Stability Properties
Autoren: Kunert, R; Schwaigerlehner, L; Mayrhofer, P;
PEGS Europe 2019
(2018) CHO cell perfusion culture development beyond 200 × 10E6 cells/mL
Autoren: Mayrhofer, P; Wiederstein, F; Damjanovic, L; Castan, A; Kunert, R
BioProcess International European Summit 2018
(2018) Does mAb germinality correlate with productivity and biophysical protein properties?
Autoren: Schwaigerlehner, L; Mayrhofer, P; Kunert, R
Antibody Engineering & Therapeutics 2018
(2018) Making the strange more familiar: Influence of germinality content on mAb expression potentials and thermal stability properties
Autoren: Schwaigerlehner, L; Mayrhofer, P; Kunert, R
18th European Congress On Biotechnology 2018
(2018) Are somatic mutations of mAbs responsible for low expression and thermal stability?
Autoren: Schwaigerlehner, L; Mayrhofer, P; Kunert, R
10th ÖGMBT Annual Meeting & Biophysics Austria Annual Meeting 2018
(2018) Humanization of a mouse antibody and subsequent analysis of expected immunogenicity by molecular dynamics simulations and in-silico T-cell epitope predictions.
Autoren: Mayrhofer, P; Schwaigerlehner, L; Oostenbrink, C; Kunert, R
Antibody Engineering & Therapeutics 2018
(2018) Does the degree of antibody maturation influence expression rate and stability of mAbs?
Autoren: Kunert, R; Schwaigerlehner, L; Mayrhofer, P
HUMAN ANTIBODIES & HYBRIDOMAS 2018
(2017) Synthesis and vaccine potential of novel oligomannosides against HIV-1
Autoren: Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R, Kosma, P.
VII EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
(2017) Rational antibody humanization assisted by molecular dynamics simulations
Autoren: Schwaigerlehner, L; Mayrhofer, P; Pechlaner, M; Oostenbrink, C; Kunert, R
9th International Conference on Recombinant Protein Production RPP9 2017
(2017) Synthesis and vaccine potential of novel oligomannosides against HIV-1
Autoren: Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P.
14th Bratislava Symposium on Saccharides BSS 2017
(2017) Rational antibody humanization assisted by molecular dynamics simulations
Autoren: Schwaigerlehner, L; Pechlaner, M; Mayrhofer, P; Oostenbrink, C; Kunert, R
25th ESACT Meeting 2017
(2017) Decision Finding For Production Systems And Expectations For The CHO System
Autoren: Kunert, R; Reinhart, D; Schwaigerlehner, L; Mundsperger, P; Hennicke, J; Sommeregger, W; Mayrhofer, P
BioBrocess Cuba 2017
(2017) Synthesis and vaccine potential of novel oligomannosides against HIV-1
Autoren: Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P.
19th European Carbohydrate Symposium 2017
(2017) Rational antibody humanization assisted by molecular dynamics simulations
Autoren: Schwaigerlehner, L; Mayrhofer, P; Pechlaner, M; Oostenbrink, C; Kunert, R
25th ESACT Meeting 2017
(2017) Antibody humanization strategies complemented with deimmunization for safe biotherapeutics
Autoren: Mayrhofer, P; Schwaigerlehner, L; Hoffmann-Freimüller, C; Geyeregger, R; Kunert, R
BioBrocess Cuba 2017
(2016) Synthesis of bacterial mimetics of HIV-1 gp120 glycans
Autoren: Trattnig, N; Pantophlet, R; Mayrhofer, P; Kunert, R; Kosma, P.
28th International Carbohydrate Symposium 2016
(2016) Investigation of different mAb expression potentials by use of complementary culture methods
Autoren: Schwaigerlehner, L; Mayrhofer, P; Kunert, R
PEGS Europe 2016
(2015) Identification of bottlenecks in antibody expression using targeted gene integration
Autoren: Mayrhofer, P; Mader, A; Kratzer, B; Reinhart, D; Steinfellner, W; Sommeregger, W; Kunert, R
24th ESACT 2015 - Cells, Culture, Patients, Products
(2014) Versatile RMCE Integration of Different Antibody Variants into Predictable Reference Sites in CHO Cells
Autoren: Mayrhofer, P; Mader, A; Kunert, R
PEGS - Protein and Antibody Engineering Summit 2014
(2014) RMCE reference sites – A valuable tool for comparing antibody expression capabilities in CHO cells
Autoren: Mayrhofer, P; Mader, A; Kunert, R
16th European Congress on Biotechnology 2014
Process intensification through cell culture perfusion
Autoren: Mayrhofer, P; Kunert, R
Does CHO gene expression change in response to expressed mAb variant?
Autoren: Schwaigerlehner, L; Akhtar, S; Scholey, R; Torres, M; Mayrhofer, P; Dickson, AJ; Kunert, R
Perfusion media development for scalable processes
Autoren: Mayrhofer, P; Kunert, R
Transient gene expression for evaluation of antibody humanization by molecular dynamics simulation
Autoren: Mayrhofer, P; Mader, A; Margreitter, C; Oostenbrink, C; Kunert, R